Literature DB >> 25169941

The impact of bacteremia on the outcome of bone infections.

P-M Roger1, E Cua2, J Courjon2, L Landraud3, M Carles4, E Bernard2.   

Abstract

UNLABELLED: We have used a medical database to analyze our activity since 2005. We observed a frequent association between bone and joint infection (BI) and bacteremia. Our aim was to characterize patients with BI and bacteremia, and focus on the outcome. PATIENTS AND
METHOD: Our database includes the prospective recording of 28 characteristics of all hospitalized patients, including diagnosis, comorbid conditions, microbiological data, therapy, and outcome. We selected patients presenting with BI in this database, from July 2005 to December 2012. Fever before blood culture was retrospectively documented from the patient's chart. Chronic BI was defined as a disease lasting more than 1 month. An unfavorable outcome was defined by the need for intensive care or death.
RESULTS: Six hundred and thirty-two patients presented with BI and 125 with bacteremia (19.8%). We used a stepwise logistic regression analysis and determined that bacteremia was associated with vertebral osteomyelitis, OR, 3.97, P<0.001; alcohol abuse, OR, 2.51, P=0.010; fever, OR, 2.43, P<0.001; neurological and/or psychiatric diseases, OR, 2.41, P ≤ 0.001; and Staphylococcus aureus infection, OR, 2.32, P<0.001. The outcome was unfavorable in 23 cases (3.6%), associated with bacteremia, OR, 8.00, P<0.001, age> 60 years, OR, 4.78, P=0.018, and S. aureus infection, OR, 3.96, P=0.010. No single comorbid condition was significantly associated with an unfavorable outcome.
CONCLUSION: Bacteremia occurred in nearly 20% of the patients presenting with BI, and was associated with identifiable comorbid conditions; it was the main risk factor for an unfavorable outcome.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Bacteremia; Bactériémie; Bone infection; Infection ostéoarticulaire; Outcome; Pronostic; Staphylococcus

Mesh:

Year:  2014        PMID: 25169941     DOI: 10.1016/j.medmal.2014.07.013

Source DB:  PubMed          Journal:  Med Mal Infect        ISSN: 0399-077X            Impact factor:   2.152


  5 in total

1.  Bacteraemic urinary tract infections may mimic respiratory infections: a nested case-control study.

Authors:  E Denis; N Martis; F Guillouet-de Salvador; E Demonchy; N Degand; K Carles; P-M Roger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-06-08       Impact factor: 3.267

2.  Adherence to antibiotic guidelines for erysipelas or cellulitis is associated with a favorable outcome.

Authors:  Camille Klotz; Johan Courjon; Céline Michelangeli; Elisa Demonchy; Raymond Ruimy; Pierre-Marie Roger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-01-26       Impact factor: 3.267

Review 3.  Diagnosis of peripheral bone and prosthetic joint infections: overview on the consensus documents by the EANM, EBJIS, and ESR (with ESCMID endorsement).

Authors:  Luca Maria Sconfienza; Alberto Signore; Victor Cassar-Pullicino; Maria Adriana Cataldo; Olivier Gheysens; Olivier Borens; Andrej Trampuz; Klaus Wörtler; Nicola Petrosillo; Heinz Winkler; Filip M H M Vanhoenacker; Paul C Jutte; Andor W J M Glaudemans
Journal:  Eur Radiol       Date:  2019-06-27       Impact factor: 5.315

4.  A Population Pharmacokinetic Analysis of Continuous Infusion of Cloxacillin during Staphylococcus aureus Bone and Joint Infections.

Authors:  Johan Courjon; Margaux Garzaro; Pierre-Marie Roger; Raymond Ruimy; Thibaud Lavrut; Mikaël Chelli; Jean-Luc Raynier; David Chirio; Elisa Demonchy; Laura Cabane; François Jehl; Christophe Trojani; Antoine Grillon; Sylvain Goutelle
Journal:  Antimicrob Agents Chemother       Date:  2020-11-17       Impact factor: 5.191

5.  Consensus document for the diagnosis of peripheral bone infection in adults: a joint paper by the EANM, EBJIS, and ESR (with ESCMID endorsement).

Authors:  Andor W J M Glaudemans; Paul C Jutte; Maria Adriana Cataldo; Victor Cassar-Pullicino; Olivier Gheysens; Olivier Borens; Andrej Trampuz; Klaus Wörtler; Nicola Petrosillo; Heinz Winkler; Alberto Signore; Luca Maria Sconfienza
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-01-24       Impact factor: 9.236

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.